$30.26
2.288.15%
Últ. Act.: Nov 9, 4:00 PM
The average analyst price target for Adaptive Biotechnologies is $23.95, 20.9% below the current price. Of 7 analysts, 7 rate it Buy. Targets range from $10 to $35. The latest change came on Oct 13, 2026, when TD Cowen raised its price target on Adaptive Biotechnologies from $28 to $32 and kept a Buy rating.
Price Target Range — 13 Quarters
Analyst Consensus — 7 Analysts
Rating Trend — Last 9 Months